3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Impaired Renal Function: new trials by email Literature Review of Impaired Renal Function trials Research Report on Impaired Renal Function
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dapagliflozin Treatment in Type 2 Diabetes Dapagliflozin 10 MG [Farxiga] - Diabetes Mellitus, Type 2, Impaired Renal Function | Phase 4 | Completed | Emerald Clinical Inc. | 17 | 2021-04-20 | 2025-04-24 |
| Linagliptin's Effect on CD34+ Stem Cells Linagliptin, Placebo - Type 2 Diabetes, Impaired Renal Function | Phase 4 | Completed | George Washington University | 31 | 2015-04-01 | 2023-01-19 |
| Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment Ezetimibe - Diabetes Mellitus, Impaired Renal Function | Phase 4 | Completed | Karolinska Institutet | 39 | 2006-01-01 | 2021-03-01 |
Renal Insufficiency (3) · Diabetes Mellitus, Type 2 (2) · Diabetes Mellitus (1)
Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Glucose Metabolism Disorders (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Diabetes Mellitus (2)
Ezetimibe (1) · Linagliptin (1) · Simvastatin (1) · dapagliflozin (1)
Emerald Clinical Inc. (1) · George Washington University (1) · Karolinska Institutet (1)
United States (2) · Canada (1) · Sweden (1)
Hiddo JL Heerspink (1) · Paul Hjemdahl, MD, PhD (1) · Sabyasachi Sen, MD, PhD (1)